Literature DB >> 17300693

Intestinal barrier dysfunction in developing liver cirrhosis: An in vivo analysis of bacterial translocation.

Pablo Palma1, Nicolas Mihaljevic, Till Hasenberg, Michael Keese, Thomas A Koeppel.   

Abstract

AIM: Transmucosal passage of bacteria across the intestine, the essential step for bacterial translocation, has been identified as a key event in the pathogenesis of life-threatening infections in cirrhosis. Existing animal models of liver cirrhosis only provide indirect information about the pathogenesis of such infections. The aim of this study has been to assess transmucosal passage and bacterial translocation directly in vivo using a rat model of developing liver cirrhosis.
METHODS: Male Sprague Dawley rats were randomly assigned to two groups: controls and animals with developing liver cirrhosis induced by s.c. injection of carbon tetrachloride. In anesthetized animals a suspension of green fluorescent protein (GFP)-tagged E. coli was administered into the terminal ileum. Time intervals necessary for translocation of E. coli into the mucosa and muscularis were assessed by intravital microscopy and translocation of E. coli in mesentery, liver and spleen was determined microbiologically.
RESULTS: Bacterial kinetics at the level of the mucosa and muscularis showed significant enhancement in cirrhotic rats compared to the controls (P < 0.001). GFP-expressing E. coli were detected in the mesentery, liver and spleen of animals with cirrhosis taken one hour after E. coli administration. However, cultures of control animals remained sterile.
CONCLUSION: Intravital microscopy of fluorescent bacteria represents a novel approach to studying bacterial translocation in vivo. Here we report that this technique can be used to visualize bacterial transit in in vivo and gives further support to the transmucosal passage of bacteria across the intestine correlating with bacterial translocation in CCl(4)-induced liver cirrhosis.

Entities:  

Year:  2007        PMID: 17300693     DOI: 10.1111/j.1872-034X.2007.00004.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  15 in total

1.  Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.

Authors:  Haifeng Lu; Zhongwen Wu; Wei Xu; Jiezuan Yang; Yunbo Chen; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-02-01       Impact factor: 4.552

2.  Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation.

Authors:  Nosratola D Vaziri; Jun Yuan; Ardeshir Rahimi; Zhenmin Ni; Hyder Said; Veedamali S Subramanian
Journal:  Nephrol Dial Transplant       Date:  2011-11-29       Impact factor: 5.992

Review 3.  Methods to determine intestinal permeability and bacterial translocation during liver disease.

Authors:  Lirui Wang; Cristina Llorente; Phillipp Hartmann; An-Ming Yang; Peng Chen; Bernd Schnabl
Journal:  J Immunol Methods       Date:  2015-01-13       Impact factor: 2.303

4.  Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Bo Jin; Xu-Jun He; Qin Zhang; Wei-Ming Zhou; Wen-Juan Xu; Huo-Xiang Lu
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

5.  Effect of salvianolate on intestinal epithelium tight junction protein zonula occludens protein 1 in cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Yuan-Jun Xie; Xu-Jun He; Wen-Juan Xu; Wei-Ming Zhou
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

6.  Host species-specific translocation of Escherichia coli.

Authors:  M Katouli; N L Ramos; C G Nettelbladt; M Ljungdahl; W Robinson; H M Ison; A Brauner; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-13       Impact factor: 3.267

Review 7.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08

8.  Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.

Authors:  Ke Wang; Zhao Zhang; Zhi-Shuo Mo; Xiao-Hua Yang; Bing-Liang Lin; Liang Peng; Yang Xu; Chun-Yan Lei; Xiao-Dong Zhuang; Ling Lu; Rui-Fu Yang; Tao Chen; Zhi-Liang Gao
Journal:  Gut Microbes       Date:  2021 Jan-Dec

9.  The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).

Authors:  Daniel Benten; Julian Schulze zur Wiesch; Karsten Sydow; Andreas Koops; Peter Buggisch; Rainer H Böger; Charlotte A Gaydos; Helen Won; Veronica Franco; Ansgar W Lohse; Stuart C Ray; Ashwin Balagopal
Journal:  BMC Gastroenterol       Date:  2011-10-06       Impact factor: 3.067

10.  Stool vs. Serum Hepatitis B Virus DNA in Patients with Chronic Hepatitis B.

Authors:  Ji-Shun Zheng; Meng-Meng Chen; Hai-Fei Yang; Xiang-Tian Zhou; Yan-Yan Liu; Jia-Bin Li
Journal:  Med Sci Monit       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.